乳房切除术后放射治疗的当代问题:简要的回顾
Caroline A Grace1, Michael J McKay1,2
1Northwest Regional Hospital, Rural Clinical School, The University of Tasmania, Burnie, TAS 7320, Australia.
Journal of clinical medicine
|January 8, 2025
概括
乳腺切除术后的放射治疗 (PMRT) 可能通过减少复发而有益于中等风险的乳腺癌患者. 目前正在研究乳房重建和低分离的PMRT.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
背景情况:
- 乳腺癌对全球健康构成重大负担.
- 乳房切除术后的放射治疗 (PMRT) 是高风险患者的标准,以防止复发.
- 它在中等风险病例中的使用以及与乳房重建一起的使用仍在争论中.
研究的目的:
- 审查PMRT有争议的方面:在中等风险疾病中的使用,与乳房重建的整合和低分化.
- 综合这些PMRT场景的当前文献和指导方针.
主要方法:
- 对现有和新兴研究的文献综述.
- 分析与PMRT指示和实践有关的指导方针.
- 讨论正在进行的临床试验.
主要成果:
- 目前的证据表明,PMRT可以改善存活率,并减少中等风险乳腺癌的局部区域复发.
- 乳房重建的时间和类型在考虑PMRT时需要个性化,多学科的决策.
- 低分离PMRT的安全性和有效性仍在调查中.
结论:
- 在中等风险乳腺癌患者中,PMRT显示出潜在的益处.
- 个性化方法对于将PMRT与乳房重建相结合至关重要.
- 进一步的研究是必不可少的,以确定低分离的PMRT的作用.
更多相关视频
相关概念视频
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K


